National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 46171 [2023-15283]

Download as PDF ddrumheller on DSK120RN23PROD with NOTICES1 Federal Register / Vol. 88, No. 137 / Wednesday, July 19, 2023 / Notices regarding progress made since the second public meeting, including protocol development, evidence review and synthesis, systematic review findings, and plans for future Committee work. The Committee will also hear oral comments from the public at this meeting. In accordance with FACA, deliberations of the Committee will occur in a public forum. Meeting Agendas: The specific agenda will be announced in advance of the meeting on DietaryGuidelines.gov. Meeting Registration: This Committee meeting is open to the public. The meeting will be accessible online via livestream and recorded for later viewing. Registration is required for the livestream and will open on Thursday, August 10, 2023. To register, go to DietaryGuidelines.gov and click on the link for ‘‘Meeting Registration.’’ Meeting materials for each meeting will be accessible at DietaryGuidelines.gov. Materials may be requested by email at DietaryGuidelines@hhs.gov. Oral Comments: The Committee invites the public to present oral comments for up to two minutes on Tuesday, September 12, 2023. Preregistration is required, and the number of commenters is limited based on the time available. Registration for oral comments will open on Thursday, August 10, 2023, at 10:00 a.m. Eastern Time. Oral comments will be confirmed on a first-come, first-served basis. Oral comments are limited to one representative per organization. All commenters’ remarks should be respectful and given in a manner that recognizes and protects the dignity of the proceedings. Oral comments should focus on the Committee’s work and be directed to the entire Committee, not individual members. Registration for Oral Comments: Requests to present oral comments can be made by going to DietaryGuidelines.gov and clicking on the link for ‘‘Meeting Registration.’’ For registration to be accepted, a written outline or a summary of the intended oral comment will be required as part of the registration process. Please limit your written outline or summary to no more than 400 words. A confirmation email with instructions will be sent to confirmed speakers from DietaryGuidelines@hhs.gov. Public Comments: A call for written public comment to the Committee opened on January 19, 2023, and will remain open throughout the Committee’s deliberations. Written comments may be submitted at VerDate Sep<11>2014 00:36 Jul 19, 2023 Jkt 259001 46171 Regulations.gov (Document ID: HHS– OASH–2022–0021–0001). DEPARTMENT OF HEALTH AND HUMAN SERVICES Paul Reed, Deputy Assistant Secretary for Health, Office of Disease Prevention and Health Promotion. National Institutes of Health [FR Doc. 2023–15342 Filed 7–18–23; 8:45 am] BILLING CODE 4150–32–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required). Date: August 10, 2023. Time: 10:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G41, Rockville, MD 20892 (Virtual Meeting). Contact Person: Kelly L. Hudspeth, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G41, Rockville, MD 20852, 240–669–5067 kelly.hudspeth@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: July 13, 2023. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–15283 Filed 7–18–23; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; NHLBI Biorepository Contract Review. Date: August 16, 2023. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Rockledge I, 6705 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Kristen Page, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 209–B, Bethesda, MD 20892, (301) 827–7953, kristen.page@nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Pediatric Heart Network Data Coordinating Center (U24). Date: August 16, 2023. Time: 1:30 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge I, 6705 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Susan Wohler Sunnarborg, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National, Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 208– Z, Bethesda, MD 20892, (301) 827–7987, susan.sunnarborg@nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Pediatric Heart Network Clinical Research Centers (UM1). Date: August 17–18, 2023. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge I, 6705 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Susan Wohler Sunnarborg, Ph.D., Scientific Review Officer, Office of E:\FR\FM\19JYN1.SGM 19JYN1

Agencies

[Federal Register Volume 88, Number 137 (Wednesday, July 19, 2023)]
[Notices]
[Page 46171]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-15283]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Clinical Trial Implementation 
Cooperative Agreement (U01 Clinical Trial Required).
    Date: August 10, 2023.
    Time: 10:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G41, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Kelly L. Hudspeth, Ph.D., Scientific Review 
Officer, Division of Extramural Activities, National Institute of 
Allergy and Infectious Diseases, National Institutes of Health, 5601 
Fishers Lane, Room 3G41, Rockville, MD 20852, 240-669-5067 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: July 13, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-15283 Filed 7-18-23; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.